title: Pregnancy-induced gingivitis and OMICS in dentistry: in silico modeling and in vivo prospective validation of estradiol-modulated inflammatory biomarkers.
abstract: Pregnancy-associated gingivitis is a bacterial-induced inflammatory disease with a remarkably high prevalence ranging from 35% to 100% across studies. Yet little is known about the attendant mechanisms or diagnostic biomarkers that can help predict individual susceptibility for rational personalized medicine. We aimed to define inflammatory proteins in saliva, induced or inhibited by estradiol, as early diagnostic biomarkers or target proteins in relation to pregnancy-associated gingivitis. An in silico gene/protein interaction network model was developed by using the STITCH 3.1 with "experiments" and "databases" as input options and a confidence score of 0.700 (high confidence). Salivary estradiol, interleukin (IL)-1β and -8, myeloperoxidase (MPO), matrix metalloproteinase (MMP)-2, -8, and -9, and tissue inhibitor of matrix metalloproteinase (TIMP)-1 levels from 30 women were measured prospectively three times during pregnancy and twice during postpartum. In silico analysis revealed that estradiol interacts with IL-1β and -8 by an activation link when the "actions view" was consulted. In saliva, estradiol concentrations associated positively with TIMP-1 and negatively with MPO and MMP-8 concentrations. When the gingival bleeding on probing percentage (BOP%) was included in the model as an effect modifier, the only association, a negative one, was found between estradiol and MMP-8. Throughout gestation, estradiol modulates the inflammatory response by inhibiting neutrophilic enzymes, such as MMP-8. The interactions between salivary degradative enzymes and proinflammatory cytokines during pregnancy suggest promising ways to identify candidate biomarkers for pregnancy-associated gingivitis, and for personalized medicine in the field of dentistry. Finally, we call for greater investments in, and action for biomarker research in periodontology and dentistry that have surprisingly lagged behind in personalized medicine compared to other fields, such as cancer research.
authors.affiliation: 1 Department of Periodontology, Institute of Dentistry, University of Turku , Turku, Finland .
authors.forename: Mervi
authors.initials: M
authors.lastname: Gürsoy
authors.forename: Fares
authors.initials: F
authors.lastname: Zeidán-Chuliá
authors.forename: Eija
authors.initials: E
authors.lastname: Könönen
authors.forename: José C F
authors.initials: JC
authors.lastname: Moreira
authors.forename: Joonas
authors.initials: J
authors.lastname: Liukkonen
authors.forename: Timo
authors.initials: T
authors.lastname: Sorsa
authors.forename: Ulvi K
authors.initials: UK
authors.lastname: Gürsoy
mesh_terms: D015415:Biomarkers / Q000378:metabolism; D003198:Computer Simulation; D003813:Dentistry / Q000639:trends*; D004958:Estradiol / Q000378:metabolism; D005260:Female; D005891:Gingivitis / Q000175:diagnosis* / Q000209:etiology; D006801:Humans; D053583:Interleukin-1beta / Q000378:metabolism; D016209:Interleukin-8 / Q000378:metabolism; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism; D020784:Matrix Metalloproteinase 8 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D009195:Peroxidase / Q000378:metabolism; D057285:Precision Medicine; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis*; D011446:Prospective Studies; D060066:Protein Interaction Maps; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000378:metabolism
chemical_list: D015415:Biomarkers; D053583:Interleukin-1beta; D016209:Interleukin-8; D019715:Tissue Inhibitor of Metalloproteinase-1; D004958:Estradiol; D009195:Peroxidase; D020778:Matrix Metalloproteinase 2; D020784:Matrix Metalloproteinase 8; D020780:Matrix Metalloproteinase 9